Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
11.58
-0.65 (-5.31%)
At close: Jul 25, 2025, 4:00 PM
12.20
+0.62 (5.35%)
After-hours: Jul 25, 2025, 7:22 PM EDT

Atara Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
13.8425.0325.8492.94106.08200.4
Upgrade
Short-Term Investments
-17.4725.88149.88264.98300.26
Upgrade
Cash & Short-Term Investments
13.8442.551.73242.82371.07500.66
Upgrade
Cash Growth
-70.07%-17.84%-78.70%-34.56%-25.88%93.22%
Upgrade
Accounts Receivable
8.881.4834.1140.220.99-
Upgrade
Other Receivables
---0.80.81.95
Upgrade
Receivables
8.881.4834.1141.021.791.95
Upgrade
Inventory
-10.669.711.59--
Upgrade
Prepaid Expenses
-----20.47
Upgrade
Restricted Cash
0.150.150.150.150.190.19
Upgrade
Other Current Assets
4.3210.126.189.5111.57-
Upgrade
Total Current Assets
27.1864.89101.87295.08384.62523.27
Upgrade
Property, Plant & Equipment
32.0141.158.7974.3279.9462.82
Upgrade
Other Long-Term Assets
2.843.14.847.023.572.03
Upgrade
Total Assets
62.04109.1165.5376.42468.13588.12
Upgrade
Accounts Payable
1.384.373.686.8717.377.12
Upgrade
Accrued Expenses
16.6121.248.5350.4144.9140.34
Upgrade
Current Portion of Leases
13.9213.9212.1813.642.751.99
Upgrade
Current Unearned Revenue
15.9895.0977.83840.7633.46
Upgrade
Total Current Liabilities
47.89134.57142.2378.92105.7982.9
Upgrade
Long-Term Leases
28.0331.5245.6958.0625.5213.04
Upgrade
Long-Term Unearned Revenue
39.3838.6272.19107.2455.7127.8
Upgrade
Other Long-Term Liabilities
1.811.674.635.561.52.04
Upgrade
Total Liabilities
117.11206.38264.74249.78188.51125.78
Upgrade
Common Stock
00-0.010.010.01
Upgrade
Additional Paid-In Capital
1,9611,9571,8701,8221,7451,587
Upgrade
Retained Earnings
-2,017-2,055-1,969-1,693-1,465-1,125
Upgrade
Comprehensive Income & Other
-0.01-0.2-2.07-0.370.3
Upgrade
Shareholders' Equity
-55.07-97.28-99.23126.64279.61462.34
Upgrade
Total Liabilities & Equity
62.04109.1165.5376.42468.13588.12
Upgrade
Total Debt
41.9445.4357.8771.728.2715.03
Upgrade
Net Cash (Debt)
-28.1-2.94-6.15171.12342.8485.63
Upgrade
Net Cash Growth
----50.08%-29.41%99.53%
Upgrade
Net Cash Per Share
-3.20-0.39-1.4541.9491.49164.13
Upgrade
Filing Date Shares Outstanding
5.965.864.773.843.723.34
Upgrade
Total Common Shares Outstanding
5.925.864.263.843.673.33
Upgrade
Working Capital
-20.71-69.68-40.36216.16278.84440.37
Upgrade
Book Value Per Share
-9.30-16.60-23.3133.0076.25138.64
Upgrade
Tangible Book Value
-55.07-97.28-99.23126.64279.61462.34
Upgrade
Tangible Book Value Per Share
-9.30-16.60-23.3133.0076.25138.64
Upgrade
Machinery
1.9117.6718.6617.8226.0519.18
Upgrade
Construction In Progress
--0.160.036.330.88
Upgrade
Leasehold Improvements
0.070.930.90.8850.1450.13
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q